Skip to content

Study the effect of Shigru patra Churna in Primary Hypothyroidism

An open labelled controlled clinical trial to study the effect of Shigru patra churna in the management of Primary Hypothyroidism - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/086025
Enrollment
70
Registered
2025-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

Dr pallavi Vinayak Jadhav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient fulfilling the laboratory diagnosis of primary hypothyroidism based on the levels of serum TSH, T3, and T4. 2.Patients having TSH level less than 15 mIU/L 3.Patient who are freshly diagnosed as hypothyroidism. 4.Patients who are already diagnosed Hypothyroidism and under Thyronorm (Levothyroxine) medication 50 gm but presenting with diagnostic criteria are included.

Exclusion criteria

Exclusion criteria: 1.Individuals diagnosed with diabetes mellitus, ischemic heart disease, uncontrolled hypertension, myocardial infarction, cerebrovascular incidents, cardiac arrhythmias, those who are pregnant, and patients with active malignant diseases were not included in the study. 2.Individuals exhibiting modified thyroid hormone levels as a result of various conditions, including under nutrition, malignant neoplasms, or non-thyroidal illnesses (commonly referred to as low-T3 syndrome). 3.Patients having TSH level greater than 15 mIU/L. 4.Recent thyroid surgery (within 12 months). 5.Patients suffering from diseases like HIV, TB, Encephalopathy, Goiter, Other endocrine disorders and other autoimmune disorders.

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms and decreasing TSH level in Primary Hypothyroidism after ingestion of Shigru patra churnaTimepoint: 3 months

Secondary

MeasureTime frame
Where the trial group stands in comparison with control group Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Pallavi Vinayak Jadhav

SMBT Ayurved College and Hospital dhamangaon igatpuri nashik

dr.mayuripawar@gmail.com8668549430

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026